The synergism of co-mutated Npm1 and Flt3-ITD in AML tumorigenesis was further demonstrated in vivo and corresponded with a pronounced overall change in lymphoid progenitor cell gene expression (127, 128). This evidence concerns the gene FLT3 and acute myeloid leukemia.